• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Sugar acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Sugar acids and derivatives

ETHYLENEDIAMINE DI-L-(+)-TARTRATE and CAS No. 996-78-1: Applications and Research Insights

The compound ETHYLENEDIAMINE DI-L-(+)-TARTRATE, identified by the CAS number 996-78-1, is a significant chemical entity with diverse applications in pharmaceuticals, biotechnology, and material science. This introduction delves into the properties, synthesis, and recent research advancements associated with this compound.

ETHYLENEDIAMINE DI-L-(+)-TARTRATE is a chiral tartrate salt derived from ethylenediamine and L-tartaric acid. Its molecular structure imparts unique physicochemical properties, making it a valuable intermediate in organic synthesis. The presence of two stereocenters enhances its versatility in forming complex molecular architectures, which is particularly relevant in the development of enantioselective catalysts and chiral auxiliaries.

In pharmaceutical research, ETHYLENEDIAMINE DI-L-(+)-TARTRATE has been explored for its potential role in drug formulation and delivery systems. Its ability to form stable complexes with various pharmacophores has been leveraged to enhance drug solubility and bioavailability. Recent studies have highlighted its application in the synthesis of prodrugs, where its chiral environment can influence metabolic pathways, thereby improving therapeutic efficacy.

The compound's utility extends to biotechnology, where it serves as a precursor in the production of chiral ligands for asymmetric catalysis. These ligands are crucial in the synthesis of biologically active molecules, including pharmaceuticals and agrochemicals. The growing demand for enantiomerically pure compounds has spurred interest in innovative synthetic methodologies involving ETHYLENEDIAMINE DI-L-(+)-TARTRATE.

Recent advancements in computational chemistry have enabled more precise predictions of the behavior of ETHYLENEDIAMINE DI-L-(+)-TARTRATE in complex systems. Molecular dynamics simulations have revealed insights into its interactions with biological targets, aiding in the design of more effective drug candidates. Additionally, machine learning models have been employed to optimize synthetic routes, reducing waste and improving yield.

The environmental impact of synthesizing ETHYLENEDIAMINE DI-L-(+)-TARTRATE has also been a focus of recent research. Green chemistry principles have guided the development of more sustainable processes, emphasizing atom economy and minimal byproduct formation. For instance, catalytic hydrogenation techniques have been explored as an alternative to traditional acid-base neutralization methods.

In material science, ETHYLENEDIAMINE DI-L-(+)-TARTRATE has been investigated for its potential as a building block in polymer synthesis. Its chiral nature allows for the creation of polymers with tailored optical and mechanical properties. These materials are being explored for applications in optoelectronics and biomedical devices, where precise control over molecular architecture is essential.

The role of CAS No. 996-78-1 in standardizing the compound's identity and properties cannot be overstated. This unique numerical identifier ensures consistency across scientific literature and industrial applications. Regulatory agencies rely on such standards to ensure safety and efficacy in pharmaceutical products derived from this compound.

The future prospects for ETHYLENEDIAMINE DI-L-(+)-TARTRATE are promising, with ongoing research uncovering new applications and refining synthetic methodologies. Collaborative efforts between academia and industry are likely to drive innovation, particularly in areas such as personalized medicine and advanced materials.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)